Patents Assigned to SABRE THERAPEUTICS LLC
  • Patent number: 11779568
    Abstract: Described herein are compounds that are autotaxin inhibitors, methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, and methods of using such compounds in the treatment of conditions, diseases, or disorders associated with autotaxin activity.
    Type: Grant
    Filed: May 6, 2022
    Date of Patent: October 10, 2023
    Assignee: Sabre Therapeutics LLC
    Inventors: John Howard Hutchinson, David Lonergan
  • Patent number: 11344533
    Abstract: Described herein are compounds that are autotaxin inhibitors, methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, and methods of using such compounds in the treatment of conditions, diseases, or disorders associated with autotaxin activity.
    Type: Grant
    Filed: May 14, 2020
    Date of Patent: May 31, 2022
    Assignee: Sabre Therapeutics LLC
    Inventors: John Howard Hutchinson, David Lonergan
  • Patent number: 10688081
    Abstract: Described herein are compounds that are autotaxin inhibitors, methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, and methods of using such compounds in the treatment of conditions, diseases, or disorders associated with autotaxin activity.
    Type: Grant
    Filed: May 3, 2018
    Date of Patent: June 23, 2020
    Assignee: SABRE THERAPEUTICS LLC
    Inventors: John Howard Hutchinson, David Lonergan
  • Patent number: 10632104
    Abstract: Described herein are methods and compositions for the treatment of conditions, diseases, or disorders associated with autotaxin activity. The methods and compositions disclosed herein include the use of at least one autotaxin inhibitor compound.
    Type: Grant
    Filed: May 24, 2016
    Date of Patent: April 28, 2020
    Assignee: SABRE THERAPEUTICS LLC
    Inventors: Gretchen Bain, Jillian Frances Evans, John Howard Hutchinson, David Lonergan